Skip to main content
. 2021 Dec 29;7(1):100341. doi: 10.1016/j.esmoop.2021.100341

Figure 2.

Figure 2

Forest plot analysis of OS and PFS in Asian patients with ESCC.

Chemo, chemotherapy; CI, confidence interval; CPS, combined positive score; ECOG PS, Eastern Cooperative Oncology Group performance status; ESCC, esophageal squamous cell carcinoma; HR, hazard ratio; OS, overall survival; PD-L1, programmed death-ligand 1; pembro, pembrolizumab; PFS, progression-free survival.